目的分析血液透析联合血液透析滤过治疗对糖尿病肾病患者营养状态、微炎症因子水平以及心功能的影响。方法选择2018年1月至2019年10月在我院住院治疗的糖尿病肾病患者150例,采用随机数字法分为对照组(76例)和观察组(74例)。对照组患者给予血液透析治疗,观察组患者给予血液透析+血液透析滤过治疗,疗程4个月。比较两组患者治疗前后的营养状态、微炎症指标及心脏结构变化情况。结果治疗前,两组患者的血红蛋白(Hb)、血清白蛋白(Alb)、铁蛋白(SF)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)、左心室收缩末期内径(LVEDs)、左心室舒张末期内径(LVEDd)、左心室后壁厚度(LVPWT)、左心房内径(LVD)水平比较,差异无统计学意义(P>0.05);治疗4个月后,观察组患者的Hb、Alb、SF水平显著高于对照组,IL-6、TNF-α、CRP水平显著低于对照组,LVEDs、LVEDd、LVPWT、LVD显著小于对照组,差异有统计学意义(P<0.05)。结论血液透析联合血液透析滤过治疗能有效改善糖尿病肾病患者的营养状况,降低微炎症因子水平,改善患者的心脏结构。
ObjectiveTo analyze the effect of hemodialysis combined with hemodiafiltration on nutritional status and microinflammatory factors and cardiac function in patients with diabetic nephropathy. MethodsA total of 150 patients with diabetic nephropathy admitted to our hospital from January 2018 to October 2019 were selected, and they were divided into control group (76 cases) and observation group (74 cases) by the random number method. The control group was treated with hemodialysis, whereas the observation group was treated with hemodialysis combined with hemodiafiltration, for a four-month treatment course. The nutritional status, microinflammatory indicators and changes in the cardiac structure before and after treatment were compared between the two groups. ResultsBefore treatment, there were no statistically significant differences in the levels of hemoglobin (Hb), serum albumin (Alb), ferritin (SF), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reaction protein (CRP), and left ventricular end-systolic diameter (LVEDs), left ventricular end-diastolic diameter (LVEDd), left ventricular posterior wall thickness (LVPWT), as well as left ventricular diameter (LVD) between the two groups (P>0.05). After 4 months of treatment, the observation group yielded higher levels of Hb, Alb, and SF, whereas lower levels of IL-6, TNF-α, and CRP, and smaller LVEDs, LVEDd, LVPWT, and LVD as compared with the control group, with statistically significant differences (P<0.05). ConclusionHemodialysis combined with hemodiafiltration can effectively improve the nutritional status of patients with diabetic nephropathy, decrease the levels of microinflammatory factors, and improve the cardiac structure in patients.